» Articles » PMID: 29371571

The Multifaceted Role of T-Helper Responses in Host Defense Against Aspergillus Fumigatus

Overview
Journal J Fungi (Basel)
Date 2018 Jan 27
PMID 29371571
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The ubiquitous opportunistic fungal pathogen rarely causes infections in immunocompetent individuals. A healthy functional innate immune system plays a crucial role in preventing -infection. This pivotal role for the innate immune system makes it a main research focus in studying the pathogenesis of aspergillosis. Although sometimes overshadowed by the innate immune response, the adaptive immune response, and in particular T-helper responses, also represents a key player in host defense against . Virtually all T-helper subsets have been described to play a role during aspergillosis, with the Th1 response being crucial for fungal clearance. However; morbidity and mortality of aspergillosis can also be partly attributed to detrimental immune responses resulting from adaptive immune activation. Th2 responses benefit fungal persistence; and are the foundation of allergic forms of aspergillosis. The Th17 response has two sides; although crucial for granulocyte recruitment, it can be involved in detrimental immunopathology. Regulatory T-cells, the endogenous regulators of inflammatory responses, play a key role in controlling detrimental inflammatory responses during aspergillosis. The current knowledge of the adaptive immune response against is summarized in this review. A better understanding on how T-helper responses facilitate clearance of -infection and control inflammation can be the fundamental basis for understanding the pathogenesis of aspergillosis and for the development of novel host-directed therapies.

Citing Articles

Lung Microbiota: From Healthy Lungs to Development of Chronic Obstructive Pulmonary Disease.

Stankovic M Int J Mol Sci. 2025; 26(4).

PMID: 40003871 PMC: 11854937. DOI: 10.3390/ijms26041403.


Damping excessive viral-induced IFN-γ rescues the impaired anti-Aspergillus host immune response in influenza-associated pulmonary aspergillosis.

Seldeslachts L, Staels F, Gkountzinopoulou M, Jacobs C, Tielemans B, Vanhoffelen E EBioMedicine. 2024; 108:105347.

PMID: 39353282 PMC: 11472711. DOI: 10.1016/j.ebiom.2024.105347.


Exploring the immunopathology of type 2 inflammatory airway diseases.

AlBloushi S, Al-Ahmad M Front Immunol. 2024; 15:1285598.

PMID: 38680486 PMC: 11045947. DOI: 10.3389/fimmu.2024.1285598.


Interplay of Cytokines and Chemokines in Aspergillosis.

Shankar J, Thakur R, Clemons K, Stevens D J Fungi (Basel). 2024; 10(4).

PMID: 38667922 PMC: 11051073. DOI: 10.3390/jof10040251.


A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting .

Kumaresan P, Wurster S, Bavisi K, da Silva T, Hauser P, Kinnitt J mBio. 2024; 15(4):e0341323.

PMID: 38415653 PMC: 11005356. DOI: 10.1128/mbio.03413-23.


References
1.
Cenci E, Mencacci A, Del Sero G, Bistoni F, Romani L . Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist. J Infect Dis. 1997; 176(1):217-26. DOI: 10.1086/514027. View

2.
Zelante T, De Luca A, DAngelo C, Moretti S, Romani L . IL-17/Th17 in anti-fungal immunity: what's new?. Eur J Immunol. 2009; 39(3):645-8. DOI: 10.1002/eji.200839102. View

3.
Armstrong-James D, Turnbull S, Teo I, Stark J, Rogers N, Rogers T . Impaired interferon-gamma responses, increased interleukin-17 expression, and a tumor necrosis factor-alpha transcriptional program in invasive aspergillosis. J Infect Dis. 2009; 200(8):1341-51. DOI: 10.1086/605931. View

4.
Osherov N . Interaction of the pathogenic mold Aspergillus fumigatus with lung epithelial cells. Front Microbiol. 2012; 3:346. PMC: 3458433. DOI: 10.3389/fmicb.2012.00346. View

5.
Murdock B, Shreiner A, McDonald R, Osterholzer J, White E, Toews G . Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. Infect Immun. 2010; 79(1):125-35. PMC: 3019910. DOI: 10.1128/IAI.00508-10. View